Company news
United Therapeutics Corporation news in 2022
United Therapeutics Corporation's news releases, calls and decks from 2022, newest first.
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
December 7, 2022
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
November 1, 2022
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
October 31, 2022
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
October 30, 2022
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022
October 25, 2022
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
October 13, 2022
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
October 10, 2022
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
September 11, 2022
United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
August 30, 2022
United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022
August 23, 2022
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
August 2, 2022
United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022
July 26, 2022
United Therapeutics Provides an Update on Its Organ Printing Programs
June 5, 2022
United Therapeutics Corporation to Present at the Jefferies Healthcare Conference
June 2, 2022
United Therapeutics Announces FDA Approval of Tyvaso DPI™
May 23, 2022
United Therapeutics Corporation Reports First Quarter 2022 Financial Results
May 3, 2022
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference
April 28, 2022
United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022
April 26, 2022
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
April 5, 2022
United Therapeutics Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
March 7, 2022
United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care Conference
February 28, 2022
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022
February 20, 2022
United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs
January 20, 2022
Calls in 2022
- United Therapeutics (NASDAQ:UTHR) Q3 2022 Earnings Call
Nov 2, 2022
Transcript - United Therapeutics (NASDAQ:UTHR) Q2 2022 Earnings Call
Aug 3, 2022
Transcript - United Therapeutics (NASDAQ:UTHR) Q1 2022 Earnings Call
May 4, 2022
Transcript - United Therapeutics (NASDAQ:UTHR) Q4 2021 Earnings Call
Feb 24, 2022
Transcript